Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Respiratory Inhalers market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Respiratory Inhalersmarket, defines the market attractiveness level of Respiratory Inhalers market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Respiratory Inhalers industry, describes the types of Respiratory Inhalers market, the applications of major players and the market size, and deeply analyzes the current situation of the global Respiratory Inhalers market and the development prospects and opportunities of Respiratory Inhalers industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Respiratory Inhalers market in Chapter 13.
By Player:
PARI Medical Holding
Boehringer Ingelheim GmbH
Koninklijke Philips NV
GlaxoSmithKline plc
Cipla Ltd
AstraZeneca
Beximco Pharmaceuticals Ltd
Merck & Co, Inc
Teva Pharmaceutical Industries Ltd
OMRON Healthcare Europe BV
By Type:
Dry Powder Inhaler
Metered Dose Inhaler
Others
By End-User:
Asthma
COPD
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Respiratory Inhalers Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Respiratory Inhalers Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Respiratory Inhalers Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Respiratory Inhalers Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Respiratory Inhalers Market Analysis and Outlook to 2022
-
7.1 Global Respiratory Inhalers Consumption (2017-2022)
-
7.2 United States Respiratory Inhalers Consumption (2017-2022)
-
7.3 Europe Respiratory Inhalers Consumption (2017-2022)
-
7.4 China Respiratory Inhalers Consumption (2017-2022)
-
7.5 Japan Respiratory Inhalers Consumption (2017-2022)
-
7.6 India Respiratory Inhalers Consumption (2017-2022)
-
7.7 South Korea Respiratory Inhalers Consumption (2017-2022)
8 Region and Country-wise Respiratory Inhalers Market Analysis and Outlook to 2028
-
8.1 Global Respiratory Inhalers Consumption Forecast (2022-2028)
-
8.2 United States Respiratory Inhalers Consumption Forecast (2022-2028)
-
8.3 Europe Respiratory Inhalers Consumption Forecast (2022-2028)
-
8.4 China Respiratory Inhalers Consumption Forecast (2022-2028)
-
8.5 Japan Respiratory Inhalers Consumption Forecast (2022-2028)
-
8.6 India Respiratory Inhalers Consumption Forecast (2022-2028)
-
8.7 South Korea Respiratory Inhalers Consumption Forecast (2022-2028)
9 Global Respiratory Inhalers Market Outlook by Types and Applications to 2022
-
9.1 Global Respiratory Inhalers Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dry Powder Inhaler Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Metered Dose Inhaler Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Respiratory Inhalers Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Asthma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global COPD Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Respiratory Inhalers Market Outlook by Types and Applications to 2028
-
10.1 Global Respiratory Inhalers Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Dry Powder Inhaler Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Metered Dose Inhaler Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Respiratory Inhalers Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global COPD Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Respiratory Inhalers Import and Export Analysis (Top 5 Countries)
-
11.1 Global Respiratory Inhalers Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Respiratory Inhalers Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Respiratory Inhalers Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Respiratory Inhalers Market Competitive Analysis
-
14.1 PARI Medical Holding
-
14.1.1 PARI Medical Holding Company Details
-
14.1.2 PARI Medical Holding Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 PARI Medical Holding Respiratory Inhalers Product and Service
-
14.2 Boehringer Ingelheim GmbH
-
14.2.1 Boehringer Ingelheim GmbH Company Details
-
14.2.2 Boehringer Ingelheim GmbH Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Boehringer Ingelheim GmbH Respiratory Inhalers Product and Service
-
14.3 Koninklijke Philips NV
-
14.3.1 Koninklijke Philips NV Company Details
-
14.3.2 Koninklijke Philips NV Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Koninklijke Philips NV Respiratory Inhalers Product and Service
-
14.4 GlaxoSmithKline plc
-
14.4.1 GlaxoSmithKline plc Company Details
-
14.4.2 GlaxoSmithKline plc Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline plc Respiratory Inhalers Product and Service
-
14.5 Cipla Ltd
-
14.5.1 Cipla Ltd Company Details
-
14.5.2 Cipla Ltd Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cipla Ltd Respiratory Inhalers Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Respiratory Inhalers Product and Service
-
14.7 Beximco Pharmaceuticals Ltd
-
14.7.1 Beximco Pharmaceuticals Ltd Company Details
-
14.7.2 Beximco Pharmaceuticals Ltd Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Beximco Pharmaceuticals Ltd Respiratory Inhalers Product and Service
-
14.8 Merck & Co, Inc
-
14.8.1 Merck & Co, Inc Company Details
-
14.8.2 Merck & Co, Inc Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck & Co, Inc Respiratory Inhalers Product and Service
-
14.9 Teva Pharmaceutical Industries Ltd
-
14.9.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.9.2 Teva Pharmaceutical Industries Ltd Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Teva Pharmaceutical Industries Ltd Respiratory Inhalers Product and Service
-
14.10 OMRON Healthcare Europe BV
-
14.10.1 OMRON Healthcare Europe BV Company Details
-
14.10.2 OMRON Healthcare Europe BV Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 OMRON Healthcare Europe BV Respiratory Inhalers Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Respiratory Inhalers
-
Figure Respiratory Inhalers Picture
-
Table Global Respiratory Inhalers Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Respiratory Inhalers Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Respiratory Inhalers Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Respiratory Inhalers Consumption by Country (2017-2022)
-
Figure United States Respiratory Inhalers Consumption and Growth Rate (2017-2022)
-
Table Europe Respiratory Inhalers Consumption and Growth Rate (2017-2022)
-
Figure China Respiratory Inhalers Consumption and Growth Rate (2017-2022)
-
Figure Japan Respiratory Inhalers Consumption and Growth Rate (2017-2022)
-
Figure India Respiratory Inhalers Consumption and Growth Rate (2017-2022)
-
Figure South Korea Respiratory Inhalers Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Inhalers Consumption Forecast by Country (2022-2028)
-
Figure United States Respiratory Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Respiratory Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Respiratory Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Respiratory Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Respiratory Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Respiratory Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dry Powder Inhaler Consumption and Growth Rate (2017-2022)
-
Figure Global Metered Dose Inhaler Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Asthma Consumption and Growth Rate (2017-2022)
-
Figure Global COPD Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Dry Powder Inhaler Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metered Dose Inhaler Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global COPD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Respiratory Inhalers Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Respiratory Inhalers Export by Region (Top 5 Countries) (2017-2028)
-
Table PARI Medical Holding (Foundation Year, Company Profile and etc.)
-
Table PARI Medical Holding Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table PARI Medical Holding Respiratory Inhalers Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Respiratory Inhalers Product and Service
-
Table Koninklijke Philips NV (Foundation Year, Company Profile and etc.)
-
Table Koninklijke Philips NV Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Koninklijke Philips NV Respiratory Inhalers Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Respiratory Inhalers Product and Service
-
Table Cipla Ltd (Foundation Year, Company Profile and etc.)
-
Table Cipla Ltd Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Ltd Respiratory Inhalers Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Respiratory Inhalers Product and Service
-
Table Beximco Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Beximco Pharmaceuticals Ltd Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beximco Pharmaceuticals Ltd Respiratory Inhalers Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Respiratory Inhalers Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Respiratory Inhalers Product and Service
-
Table OMRON Healthcare Europe BV (Foundation Year, Company Profile and etc.)
-
Table OMRON Healthcare Europe BV Respiratory Inhalers Sales, Price, Value and Gross Profit (2017-2022)
-
Table OMRON Healthcare Europe BV Respiratory Inhalers Product and Service
-
